As of 2026-03-03, the Relative Valuation of AxoGen Inc (AXGN) is (10.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 30.65 USD, the upside of AxoGen Inc based on Relative Valuation is -133.6%.
The range of the Relative Valuation is (10.26) - (10.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.7x - 41.1x | 37.3x |
| Forward P/E multiples | 23.1x - 33.7x | 28.4x |
| Fair Price | (10.26) - (10.57) | (10.30) |
| Upside | -133.5% - -134.5% | -133.6% |
| Date | P/E |
| 2026-02-27 | -101.27 |
| 2026-02-26 | -101.82 |
| 2026-02-25 | -99.65 |
| 2026-02-24 | -103.73 |
| 2026-02-23 | -112.92 |
| 2026-02-20 | -112.67 |
| 2026-02-19 | -111.74 |
| 2026-02-18 | -112.51 |
| 2026-02-17 | -110.56 |
| 2026-02-13 | -106.06 |
| 2026-02-12 | -104.08 |
| 2026-02-11 | -108.20 |
| 2026-02-10 | -110.15 |
| 2026-02-09 | -108.30 |
| 2026-02-06 | -111.49 |
| 2026-02-05 | -108.20 |
| 2026-02-04 | -109.22 |
| 2026-02-03 | -112.38 |
| 2026-02-02 | -111.77 |
| 2026-01-30 | -111.23 |
| 2026-01-29 | -108.52 |
| 2026-01-28 | -108.87 |
| 2026-01-27 | -110.40 |
| 2026-01-26 | -110.82 |
| 2026-01-23 | -104.79 |
| 2026-01-22 | -102.14 |
| 2026-01-21 | -105.36 |
| 2026-01-20 | -101.72 |
| 2026-01-16 | -99.01 |
| 2026-01-15 | -99.65 |
| 2026-01-14 | -98.31 |
| 2026-01-13 | -98.72 |
| 2026-01-12 | -100.70 |
| 2026-01-09 | -106.96 |
| 2026-01-08 | -106.51 |
| 2026-01-07 | -105.17 |
| 2026-01-06 | -99.10 |
| 2026-01-05 | -101.37 |
| 2026-01-02 | -98.94 |
| 2025-12-31 | -104.47 |
| 2025-12-30 | -104.47 |
| 2025-12-29 | -106.76 |
| 2025-12-26 | -104.69 |
| 2025-12-24 | -104.18 |
| 2025-12-23 | -104.82 |
| 2025-12-22 | -104.50 |
| 2025-12-19 | -102.07 |
| 2025-12-18 | -101.18 |
| 2025-12-17 | -100.19 |
| 2025-12-16 | -93.68 |